Brand Refactoring, the largest shareholder of Kosdaq-listed Dong Sung Pharmaceutical, stated on September 26 that recent media reports alleging ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback